Generics in India
Description
Generics in India
Summary
Generics in India industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Generics in India industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
- The Indian generics market recorded revenues of $36.6 billion in 2024, representing a compound annual growth rate (CAGR) of 7.0% between 2019 and 2024.
- Market consumption volume increased with a CAGR of 0.2% between 2019 and 2024, reaching a total of 99.0% of total pharma volume in 2024.
- In 2024, the revenue of the Indian generics market experienced an annual growth of 7.3%. The market’s growth is driven by the country’s aging population. According to the US Census Bureau, in 2024, the population aged 65 years and above in India reached 99.1 million, up 1.2% from 2023.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in India
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in India
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the India generics market with five year forecasts by both value and volume
- What was the size of the India generics market by value in 2024?
- What will be the size of the India generics market in 2029?
- What factors are affecting the strength of competition in the India generics market?
- How has the market performed over the last five years?
- What are the main segments that make up India's generics market?
Table of Contents
48 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Market volume
- 1.4. Market volume forecast
- 1.5. Geography segmentation
- 1.6. Market rivalry
- 1.7. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 3.2. Market volume
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 5.2. Market volume forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strategies of the leading players?
- 7.3. What are the most recent market developments?
- 8 Company Profiles
- 8.1. Sun Pharmaceutical Industries Ltd
- 8.2. Cipla Ltd
- 8.3. Lupin Ltd
- 8.4. Aurobindo Pharma Ltd
- 8.5. Dr. Reddy's Laboratories Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: India generics market value: $ million, 2019-24
- Table 2: India generics market volume: % of total pharma volume, 2019-24
- Table 3: India generics market geography segmentation: $ million, 2024
- Table 4: India generics market value forecast: $ million, 2024-29
- Table 5: India generics market volume forecast: % of total pharma volume, 2024-29
- Table 6: Sun Pharmaceutical Industries Ltd: Key Facts
- Table 7: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
- Table 8: Sun Pharmaceutical Industries Ltd: Key Employees
- Table 9: Cipla Ltd: Key Facts
- Table 10: Cipla Ltd: Annual Financial Ratios
- Table 11: Cipla Ltd: Key Employees
- Table 12: Lupin Ltd: Key Facts
- Table 13: Lupin Ltd: Annual Financial Ratios
- Table 14: Lupin Ltd: Key Employees
- Table 15: Aurobindo Pharma Ltd: Key Facts
- Table 16: Aurobindo Pharma Ltd: Annual Financial Ratios
- Table 17: Aurobindo Pharma Ltd: Key Employees
- Table 18: Aurobindo Pharma Ltd: Key Employees Continued
- Table 19: Dr. Reddy's Laboratories Ltd: Key Facts
- Table 20: Dr. Reddy's Laboratories Ltd: Annual Financial Ratios
- Table 21: Dr. Reddy's Laboratories Ltd: Key Employees
- Table 22: India Size of Population (Million), 2020-24
- Table 23: India Real GDP (Constant 2010 Prices, $ Billion), 2020-24
- Table 24: India GDP (Current Prices, $ Billion), 2020-24
- Table 25: India Inflation, 2020-24
- Table 26: India Consumer Price Index (Absolute), 2020-24
- Table 27: India Exchange Rate, 2019-24
- List of Figures
- Figure 1: India generics market value: $ million, 2019-24
- Figure 2: India generics market volume: % of total pharma volume, 2019-24
- Figure 3: India generics market geography segmentation: % share, by value, 2024
- Figure 4: India generics market value forecast: $ million, 2024-29
- Figure 5: India generics market volume forecast: % of total pharma volume, 2024-29
- Figure 6: Forces driving competition in the generics market in India, 2024
- Figure 7: Drivers of buyer power in the generics market in India, 2024
- Figure 8: Drivers of supplier power in the generics market in India, 2024
- Figure 9: Factors influencing the likelihood of new entrants in the generics market in India, 2024
- Figure 10: Factors influencing the threat of substitutes in the generics market in India, 2024
- Figure 11: Drivers of degree of rivalry in the generics market in India, 2024
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



